Related Experiment Videos
Laparoscopic splenectomy for non-Hodgkin lymphoma
1Department of General Surgery, Cleveland Clinic Foundation, Ohio, USA.
Journal of Surgical Oncology
|March 20, 1999
Summary
Laparoscopic splenectomy is a feasible and safe procedure for patients with non-Hodgkin lymphoma (NHL) and splenomegaly. This minimally invasive approach offers successful outcomes without mortality or major complications.
Area of Science:
- Minimally invasive surgery
- Oncology
- Surgical gastroenterology
Background:
- Splenic involvement is common in non-Hodgkin lymphoma (NHL).
- Splenectomy is indicated for symptom management, cytopenias, or diagnosis in NHL patients.
- Massive splenomegaly can pose surgical challenges.
Purpose of the Study:
- To assess the feasibility of laparoscopic splenectomy for patients with splenomegaly and suspected NHL.
Main Methods:
- Retrospective review of patients undergoing laparoscopic splenectomy for suspected NHL.
- Analysis of operative time, blood loss, complications, and patient outcomes.
Main Results:
- 9 out of 57 laparoscopic splenectomies were performed for NHL.
- Patients presented with significant splenomegaly (mean 17.8 cm length, 765 gm weight).
- The procedure demonstrated low blood loss (108 cc), no conversions to open surgery, no mortality, and short hospital stays (2-4 days).
Conclusions:
- Laparoscopic splenectomy is a viable option for splenomegaly in NHL patients.
- The lateral position is recommended for optimal surgical outcomes.
- The technique is safe and effective, even in cases of massive splenomegaly, with no major complications reported at follow-up.